お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
737889

非経口栄養の世界市場:分析、シェア、動向、規模、予測

Parenteral Nutrition Market, By Nutrient Type (Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, Single Dose Amino Acid Solution, and Vitamins & Minerals) and Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 143 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.77円
非経口栄養の世界市場:分析、シェア、動向、規模、予測
出版日: 2018年09月28日
発行: AnalystView Market Insights
ページ情報: 英文 143 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の非経口栄養市場について調査分析し、市場概要、市場動向、産業分析、市場情勢、セグメント別の市場分析、主要ベンダー分析について、体系的な情報を提供しています。

第1章 非経口栄養:市場概要

  • 調査範囲
  • 前提条件と調査手法

第2章 エグゼクティブサマリー

第3章 非経口栄養:主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 非経口栄養:産業分析

  • ファイブフォース分析
  • 市場の魅力分析
  • 規制の枠組み分析

第5章 非経口栄養:市場情勢

  • 市場シェア分析

第6章 非経口栄養市場:栄養の種類別

  • 概要
  • 非経口脂肪乳剤
  • 炭水化物
  • 微量元素
  • 単回投与アミノ酸溶液
  • ビタミン・ミネラル

第7章 非経口栄養市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域

第8章 主要ベンダー分析

  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Baxter International, Inc.
  • Pfizer, Inc.
  • Allergan Plc

第9章 アナリストの見解

第10章 付録

図表

List of Tables

  • Table 1 List of Acronyms
  • Table 2 Key Market Facts, 2014 - 2025
  • Table 3 Market Drivers: Impact Analysis
  • Table 4 Market Restraint: Impact Analysis
  • Table 5 Market Opportunity: Impact Analysis
  • Table 6 PEST Analysis
  • Table 7 Porter's Five Forces Analysis
  • Table 8 Company Market Share Analysis
  • Table 9 Global Parenteral Nutrition Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • Table 10 Parenteral Nutrition Market, by Nutrient Type, 2014 - 2025 (USD Billion)
  • Table 11 Parenteral Nutrition Market, by Geography, 2014 - 2025 (USD Billion)
  • Table 12 North America Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 13 U.S. Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 14 Canada Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 15 Europe Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 16 France Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 17 Germany Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 18 Asia Pacific Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 19 China Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 20 India Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 21 Latin America Parenteral Nutrition Market, 2014 - 2025 (USD Billion)
  • Table 22 MEA Parenteral Nutrition Market, 2014 - 2025 (USD Billion)

List of Figures

  • Figure 1 Research Methodology
  • Figure 2 Research Process Flow Chart
  • Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
  • Figure 4 Regulatory Framework Analysis
  • Figure 5 Parenteral Nutrition Market, by Nutrient Type, 2014 - 2025 (USD Billion)
  • Figure 6 Parenteral Nutrition Market, by Geography, 2014 - 2025 (USD Billion)
目次
Product Code: AV200

Report Hightlights

The parenteral nutrition market is estimated to represent a global market of USD 4.93 billion by 2017 with growth rate of 6.1%.

Market Dynamics

Parenteral nutrition (also termed as Total Parenteral Nutrition) is a sterile solution that contains macronutrient (i.e. lipid, carbohydrate etc.) and micronutrient (minerals, vitamins etc.). The solution is directly infused into the bloodstream through an intravenous infusion pump, bypassing the digestive system. Special types of intravenous catheters such as Broviac, Hickman, and triple or double lumen catheters are used for this purpose. The growth of this industry is majorly attributed to the rising number of malnutrition cases across the globe. According to the Global Alliance for Improved Nutrition, more than two billion people suffer from a different form of malnutrition worldwide. As per the organization, globally, more than 2.6 million children die due to the lack of proper nutrition every year.

Parenteral nutrition enables an individual in achieving proper nutritional intake in a timely manner. Thereby, the demand for nutrient uptake through the parenteral route is increasing with the rising number of people with malnutrition, driving the industry growth. Other factors such as an aging population coupled with rising prevalence of chronic medical conditions spur the growth of this industry over the forecast period. On the contrary, potential complications associated with parenteral nutrition such as Intravenous access-related trauma, Air embolus, and Thrombophlebitis hampers the market growth to some extent.

Nutrient Type Takeaway

In terms of nutrient type, the market is categorized as Parenteral Lipid Emulsion, Carbohydrates, Trace elements, Single Dose Amino Acid Solution, and Vitamins & Minerals. Single dose amino acid solution accounted for the highest share. In 2017, the segment recorded USD 1.5 billion and is projected to dominate the industry over the study period. Developing regions such as the Asia Pacific and Latin America are the target market for single dose amino acid solutions owing to the rising incidences of protein deficiency diseases such as Kwashiorkor and Marasmus. Nirmin (Nirlife Pharma) and Aminosyn (Hospira, Inc.) are some of the commercially available products under this segment. However, parenteral lipid emulsions and carbohydrates are anticipated to grow with a lucrative growth rate over the study period.

Global Parenteral Nutrition Market, by Nutrient Type, 2017 vs 2025

Regional Takeaway

Region wise, North America and Europe accounted for more than 75% revenue share collectively in 2017. Aggressive strategies adopted by leading players to expand their presence in these regions act as a potential driver for industry growth. For instance, in August 2017, Baxter collaborated with the American Society for Parenteral and Enteral Nutrition (ASPEN) which aims to increase awareness regarding the appropriate use of nutritional therapy.

The initiation is named as "SmartPN" that provides healthcare professionals with educational tools on the proper use of PN therapy that helps in reducing malnutrition cases and achieve better health outcomes. Asia Pacific accounted for over 14% revenue share in 2017 and is projected to grow with 6.9% CAGR over the study period. Growing geriatric population, rising demand for home healthcare coupled with increasing prevalence of chronic diseases support the regional growth.

Key Vendor Takeaway

Key players such as Fresenius Kabi AG, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., and Allergan Plc are operating in this market. These key players are actively involved in improving the current portfolio of parenteral nutrition in order to sustain their position in the market. For example, Baxter offers one of the broadest portfolios under parenteral nutrition segment, which includes vitamins and lipids, premix IV solutions, as well as labelling, pharmacy workflow management, and compounding technology. Additionally, the company received marketing authorization for its product NUMETA G13E from the competent authorities in the Denmark and U.K.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2014 & 2016

Base Year - 2017

Estimated Year - 2018

Projected Year - 2025

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Hospitals

Government and Regional Agencies and Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY NUTRIENT TYPE

Parenteral Lipid Emulsion

Carbohydrates

Trace Elements

Single Dose Amino Acid Solution

Vitamins & Minerals

MARKET, BY REGION

North America

U.S.

Canada

Europe

Germany

France

Rest of Europe

Asia Pacific

India

China

Rest of APAC

Rest of the World

Middle East and Africa

Latin America

TABLE OF CONTENTS

1. PARENTERAL NUTRITION MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Key Market Facts
  • 2.2. Geographical Scenario
  • 2.3. Companies in the Market

3. PARENTERAL NUTRITION KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. PARENTERAL NUTRITION INDUSTRY STUDY

  • 4.1. Porter's Analysis
  • 4.2. Market Attractiveness Analysis
  • 4.3. Regulatory Framework Analysis

5. PARENTERAL NUTRITION MARKET LANDSCAPE

  • 5.1. Market Share Analysis

6. PARENTERAL NUTRITION MARKET - BY NUTRIENT TYPE

  • 6.1. Overview
  • 6.2. Parenteral Lipid Emulsion
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.3. Carbohydrates
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.4. Trace Elements
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.5. Single Dose Amino Acid Solution
    • 6.5.1. Overview
    • 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.6. Vitamins & Minerals
    • 6.6.1. Overview
    • 6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

7. PARENTERAL NUTRITION MARKET- BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.2.3. U.S.
    • 7.2.3.1. Overview
    • 7.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.2.4. Canada
    • 7.2.4.1. Overview
    • 7.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.3. Europe
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.3.3. France
    • 7.3.3.1. Overview
    • 7.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.3.4. Germany
    • 7.3.4.1. Overview
    • 7.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.3.5. Rest of Europe
    • 7.3.5.1. Overview
    • 7.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.4. Asia Pacific (APAC)
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.4.3. China
    • 7.4.3.1. Overview
    • 7.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.4.4. India
    • 7.4.4.1. Overview
    • 7.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.4.5. Rest of APAC
    • 7.4.5.1. Overview
    • 7.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.5. Rest of the World
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.5.3. Latin America
    • 7.5.3.1. Overview
    • 7.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 7.5.4. Middle East and Africa
    • 7.5.4.1. Overview
    • 7.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

8. KEY VENDOR ANALYSIS

  • 8.1. B. Braun Melsungen AG
    • 8.1.1. Company Overview
    • 8.1.2. SWOT Analysis
    • 8.1.3. Key Developments
  • 8.2. Fresenius Kabi AG
    • 8.2.1. Company Overview
    • 8.2.2. SWOT Analysis
    • 8.2.3. Key Developments
  • 8.3. Baxter International, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. SWOT Analysis
    • 8.3.3. Key Developments
  • 8.4. Pfizer, Inc.
    • 8.4.1. Company Overview
    • 8.4.2. SWOT Analysis
    • 8.4.3. Key Developments
  • 8.5. Allergan Plc
    • 8.5.1. Company Overview
    • 8.5.2. SWOT Analysis
    • 8.5.3. Key Developments

Client can request additional company profiling as per specific requirements

9. 360 DEGREE ANALYSTVIEW

10. APPENDIX

  • 10.1. Research Methodology
  • 10.2. Abbreviations
  • 10.3. Disclaimer
  • 10.4. Contact Us
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.